Prime Medicine, Inc Common Stock

Prime Medicine, Inc Common Stock

Quarterly Financials

Values in thousands2026-09-302026-06-302026-03-312025-12-31
Revenue
$4,213
$1,154
$856
$838
Gross Profit
-39,926
1,154
-1,000
838
EBITDA
-37,284
-40,324
-47,266
-44,203
EBIT
-39,043
-42,109
-49,122
-46,079
Net Income
-39,043
-42,109
-49,122
-46,079
Net Change In Cash
4,213
1,154
856
838
Free Cash Flow
-36,981
-41,092
-42,924
-37,546
Cash
54,886
47,451
64,106
63,032
Basic Shares
177,857
177,224
177,096
148,758

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$4,632
$2,983
$0
$5,210
Gross Profit
-2,689
2,983
-4,653
-12,014
EBITDA
-195,758
-189,754
-186,639
-120,545
EBIT
-201,142
-195,882
-191,292
-122,769
Net Income
-201,142
-195,882
-198,133
-121,821
Net Change In Cash
4,632
2,983
0
5,210
Cost of Revenue
2,571
Free Cash Flow
-167,095
-130,159
-174,136
-147,922
Cash
63,032
182,476
41,574
187,620
Basic Shares
148,758
118,600
90,969
97,209

Earnings Calls

QuarterEPS
2026-09-30
-$0.22
2026-06-30
-$0.24
2026-03-31
-$0.28
2025-12-31
-$0.24